• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Femasys Inc. - Common Stock (NQ:FEMY)

    2.815 -0.245 (-8.01%)
    Streaming Delayed Price Updated: 11:16 AM EDT, Jul 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 72,298
    Open 3.080
    Bid (Size) 2.770 (500)
    Ask (Size) 2.860 (100)
    Prev. Close 3.060
    Today's Range 2.730 - 3.080
    52wk Range 2.895 - 22.20
    Shares Outstanding 11,813,610
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Femasys Regains Compliance with Nasdaq Listing Requirements
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More ↗
    Innoviva develops respiratory pharmaceuticals through strategic partnerships and royalty agreements in the global healthcare market. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    -77.9%
    -77.9%
    1 Month
    -24.7%
    -24.7%
    3 Month
    -64.0%
    -64.0%
    6 Month
    -76.5%
    -76.5%
    1 Year
    -83.7%
    -83.7%

    More News

    Read More
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    Get insights into the top gainers and losers of Friday's after-hours session. ↗
    Via Chartmill
    News headline image
    Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update
    From Femasys Inc.
    Via GlobeNewswire
    Traders are paying attention to the gapping stocks in Monday's session. ↗
    Via Chartmill
    News headline image
    Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Announces FemBloc® Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Traders are paying attention to the gapping stocks in Monday's session. ↗
    Via Chartmill
    News headline image
    Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device
    From Femasys Inc.
    Via GlobeNewswire
    News headline image
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    PMCB Stock Jumps 25% After Company Sells Stake In Femasys ↗
    Via Stocktwits
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Femasys Announces Third Quarter Financial Results for 2025
    From Femasys Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Femasys Inc. - Common Stock publicly traded?
    Yes, Femasys Inc. - Common Stock is publicly traded.
    What exchange does Femasys Inc. - Common Stock trade on?
    Femasys Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Femasys Inc. - Common Stock?
    The ticker symbol for Femasys Inc. - Common Stock is FEMY on the Nasdaq Stock Market
    What is the current price of Femasys Inc. - Common Stock?
    The current price of Femasys Inc. - Common Stock is 2.815
    When was Femasys Inc. - Common Stock last traded?
    The last trade of Femasys Inc. - Common Stock was at 07/28/26 11:16 AM ET
    What is the market capitalization of Femasys Inc. - Common Stock?
    The market capitalization of Femasys Inc. - Common Stock is 33.26M
    How many shares of Femasys Inc. - Common Stock are outstanding?
    Femasys Inc. - Common Stock has 33M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.